SG5

2,3,4-tri-O-propanoyl-6-O-sulfamoyl-alpha-D-glucopyranose

Created:	2011-08-19
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where SG5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	5
Bond Count	53
Aromatic Bond Count	0

2D diagram of SG5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,3,4-tri-O-propanoyl-6-O-sulfamoyl-alpha-D-glucopyranose
Synonyms	2,3,4-tri-O-propanoyl-6-O-sulfamoyl-alpha-D-glucose; 2,3,4-tri-O-propanoyl-6-O-sulfamoyl-D-glucose; 2,3,4-tri-O-propanoyl-6-O-sulfamoyl-glucose
Systematic Name (OpenEye OEToolkits)	[(2R,3R,4S,5R,6S)-6-oxidanyl-4,5-di(propanoyloxy)-2-(sulfamoyloxymethyl)oxan-3-yl] propanoate
Formula	C₁₅ H₂₅ N O₁₁ S
Molecular Weight	427.424
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(OCC1OC(O)C(OC(=O)CC)C(OC(=O)CC)C1OC(=O)CC)N
SMILES	CACTVS	3.370	CCC(=O)O[CH]1[CH](O)O[CH](CO[S](N)(=O)=O)[CH](OC(=O)CC)[CH]1OC(=O)CC
SMILES	OpenEye OEToolkits	1.7.2	CCC(=O)OC1C(OC(C(C1OC(=O)CC)OC(=O)CC)O)COS(=O)(=O)N
Canonical SMILES	CACTVS	3.370	CCC(=O)O[C@H]1[C@@H](O)O[C@H](CO[S](N)(=O)=O)[C@@H](OC(=O)CC)[C@@H]1OC(=O)CC
Canonical SMILES	OpenEye OEToolkits	1.7.2	CCC(=O)O[C@@H]1[C@H](O[C@@H]([C@@H]([C@H]1OC(=O)CC)OC(=O)CC)O)COS(=O)(=O)N
InChI	InChI	1.03	InChI=1S/C15H25NO11S/c1-4-9(17)25-12-8(7-23-28(16,21)22)24-15(20)14(27-11(19)6-3)13(12)26-10(18)5-2/h8,12-15,20H,4-7H2,1-3H3,(H2,16,21,22)/t8-,12-,13+,14-,15+/m1/s1
InChIKey	InChI	1.03	TUQHVAPJYYJQSN-WMNSZERYSA-N

Related Resource References

Resource Name	Reference
PubChem	137349997

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.